nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC6A14—mammary gland—lung cancer	0.0224	0.496	CbGeAlD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ABCC3—lung cancer	0.0145	0.0679	CbGpPWpGaD
Valaciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0102	0.0478	CbGpPWpGaD
Valaciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00851	0.0399	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—HMGB2—lung cancer	0.0084	0.0394	CbGpPWpGaD
Valaciclovir—SLC6A14—lung—lung cancer	0.00792	0.176	CbGeAlD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ABCC3—lung cancer	0.00757	0.0355	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—AKR1C1—lung cancer	0.00734	0.0344	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00702	0.0329	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00523	0.0245	CbGpPWpGaD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ALB—lung cancer	0.00461	0.0216	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—lung cancer	0.00441	0.0207	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	0.00374	0.0175	CbGpPWpGaD
Valaciclovir—SLC15A2—mammary gland—lung cancer	0.00353	0.0782	CbGeAlD
Valaciclovir—SLC6A14—NRF2 pathway—PRDX1—lung cancer	0.00351	0.0164	CbGpPWpGaD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00332	0.0156	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM2—lung cancer	0.0033	0.0154	CbGpPWpGaD
Valaciclovir—SLC15A1—epithelium—lung cancer	0.00314	0.0697	CbGeAlD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00314	0.0147	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00308	0.0144	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	0.00303	0.0142	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—lung cancer	0.00275	0.0129	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA3—lung cancer	0.00266	0.0125	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—KEAP1—lung cancer	0.0025	0.0117	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA4—lung cancer	0.00243	0.0114	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—lung cancer	0.00241	0.0113	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00238	0.0111	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA2—lung cancer	0.00237	0.0111	CbGpPWpGaD
Valaciclovir—SLC15A2—respiratory system—lung cancer	0.00235	0.0521	CbGeAlD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA1—lung cancer	0.00229	0.0107	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—ABCC3—lung cancer	0.00226	0.0106	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—UGT1A1—lung cancer	0.00213	0.00995	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00204	0.00957	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—NFE2L2—lung cancer	0.00201	0.00944	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.002	0.00939	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	0.00199	0.0093	CbGpPWpGaD
Valaciclovir—SLC15A2—bronchus—lung cancer	0.00194	0.0429	CbGeAlD
Valaciclovir—SLC6A14—NRF2 pathway—TGFA—lung cancer	0.00192	0.009	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00174	0.00817	CbGpPWpGaD
Valaciclovir—SLC15A2—trachea—lung cancer	0.00174	0.0385	CbGeAlD
Valaciclovir—SLC6A14—NRF2 pathway—GCLC—lung cancer	0.00173	0.00811	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—CYP2A6—lung cancer	0.00173	0.00811	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00171	0.00799	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00159	0.00747	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.00152	0.00712	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00148	0.00695	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—NQO1—lung cancer	0.00146	0.00682	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00138	0.00645	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00132	0.00619	CbGpPWpGaD
Valaciclovir—SLC15A2—lung—lung cancer	0.00125	0.0277	CbGeAlD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00122	0.00574	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—lung cancer	0.00121	0.00569	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00121	0.00566	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00118	0.00553	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00112	0.00527	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM1—lung cancer	0.00112	0.00523	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CREBBP—lung cancer	0.0011	0.00516	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	0.00109	0.00512	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00104	0.00489	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00102	0.00479	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000928	0.00435	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—COL4A3BP—lung cancer	0.000893	0.00418	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AZIN2—lung cancer	0.000893	0.00418	CbGpPWpGaD
Valaciclovir—SLC15A2—lymph node—lung cancer	0.000854	0.0189	CbGeAlD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000832	0.0039	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000806	0.00378	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000791	0.00371	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000775	0.00363	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ATP5H—lung cancer	0.000759	0.00356	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000754	0.00353	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—AVP—lung cancer	0.000748	0.00351	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000724	0.00339	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000718	0.00336	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.0007	0.00328	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000698	0.00327	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLBD1—lung cancer	0.000677	0.00317	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000665	0.00312	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—GNG11—lung cancer	0.000656	0.00307	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000645	0.00302	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000645	0.00302	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000622	0.00292	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSD17B10—lung cancer	0.000619	0.0029	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TF—lung cancer	0.0006	0.00281	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG2—lung cancer	0.00059	0.00276	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ADCY1—lung cancer	0.00059	0.00276	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CKB—lung cancer	0.000575	0.00269	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000571	0.00268	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TF—lung cancer	0.000549	0.00257	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM2—lung cancer	0.000541	0.00253	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CNDP2—lung cancer	0.000541	0.00253	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00053	0.00248	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTMR3—lung cancer	0.000526	0.00246	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00052	0.00243	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PGAM1—lung cancer	0.000513	0.0024	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2A7—lung cancer	0.000489	0.00229	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SDC4—lung cancer	0.000479	0.00224	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000472	0.00221	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—lung cancer	0.000453	0.00212	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—RRM1—lung cancer	0.000436	0.00204	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA3—lung cancer	0.000436	0.00204	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AVP—lung cancer	0.000416	0.00195	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—B4GALT5—lung cancer	0.00041	0.00192	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000403	0.00189	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA4—lung cancer	0.000399	0.00187	CbGpPWpGaD
Valaciclovir—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000395	0.000532	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000394	0.00184	CbGpPWpGaD
Valaciclovir—Vomiting—Vinorelbine—lung cancer	0.000393	0.00053	CcSEcCtD
Valaciclovir—Body temperature increased—Gemcitabine—lung cancer	0.000393	0.000529	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—lung cancer	0.000391	0.000528	CcSEcCtD
Valaciclovir—Rash—Vinorelbine—lung cancer	0.00039	0.000526	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.00039	0.00183	CbGpPWpGaD
Valaciclovir—Dermatitis—Vinorelbine—lung cancer	0.000389	0.000525	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTA2—lung cancer	0.000389	0.00182	CbGpPWpGaD
Valaciclovir—Stomatitis—Methotrexate—lung cancer	0.000388	0.000524	CcSEcCtD
Valaciclovir—Headache—Vinorelbine—lung cancer	0.000387	0.000522	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—lung cancer	0.000387	0.000522	CcSEcCtD
Valaciclovir—Leukopenia—Docetaxel—lung cancer	0.000387	0.000521	CcSEcCtD
Valaciclovir—Feeling abnormal—Cisplatin—lung cancer	0.000381	0.000514	CcSEcCtD
Valaciclovir—Paraesthesia—Etoposide—lung cancer	0.000381	0.000514	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AVP—lung cancer	0.00038	0.00178	CbGpPWpGaD
Valaciclovir—Haematuria—Methotrexate—lung cancer	0.00038	0.000512	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000379	0.000511	CcSEcCtD
Valaciclovir—Dyspnoea—Etoposide—lung cancer	0.000378	0.00051	CcSEcCtD
Valaciclovir—Somnolence—Etoposide—lung cancer	0.000377	0.000508	CcSEcCtD
Valaciclovir—Cough—Docetaxel—lung cancer	0.000377	0.000508	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—lung cancer	0.000377	0.000508	CcSEcCtD
Valaciclovir—Insomnia—Paclitaxel—lung cancer	0.000376	0.000507	CcSEcCtD
Valaciclovir—Hypersensitivity—Irinotecan—lung cancer	0.000376	0.000507	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTA1—lung cancer	0.000375	0.00176	CbGpPWpGaD
Valaciclovir—Convulsion—Docetaxel—lung cancer	0.000374	0.000505	CcSEcCtD
Valaciclovir—Paraesthesia—Paclitaxel—lung cancer	0.000373	0.000504	CcSEcCtD
Valaciclovir—Hypertension—Docetaxel—lung cancer	0.000373	0.000503	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—lung cancer	0.000372	0.000502	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ABCC3—lung cancer	0.000371	0.00174	CbGpPWpGaD
Valaciclovir—Dyspnoea—Paclitaxel—lung cancer	0.000371	0.0005	CcSEcCtD
Valaciclovir—Somnolence—Paclitaxel—lung cancer	0.00037	0.000499	CcSEcCtD
Valaciclovir—Decreased appetite—Etoposide—lung cancer	0.000369	0.000497	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000368	0.00173	CbGpPWpGaD
Valaciclovir—Chest pain—Docetaxel—lung cancer	0.000368	0.000496	CcSEcCtD
Valaciclovir—Myalgia—Docetaxel—lung cancer	0.000368	0.000496	CcSEcCtD
Valaciclovir—Arthralgia—Docetaxel—lung cancer	0.000368	0.000496	CcSEcCtD
Valaciclovir—Nausea—Vinorelbine—lung cancer	0.000367	0.000495	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Etoposide—lung cancer	0.000366	0.000494	CcSEcCtD
Valaciclovir—Dyspepsia—Paclitaxel—lung cancer	0.000366	0.000494	CcSEcCtD
Valaciclovir—Body temperature increased—Cisplatin—lung cancer	0.000366	0.000494	CcSEcCtD
Valaciclovir—Asthenia—Irinotecan—lung cancer	0.000366	0.000493	CcSEcCtD
Valaciclovir—Fatigue—Etoposide—lung cancer	0.000366	0.000493	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000365	0.000492	CcSEcCtD
Valaciclovir—Constipation—Etoposide—lung cancer	0.000363	0.000489	CcSEcCtD
Valaciclovir—Pain—Etoposide—lung cancer	0.000363	0.000489	CcSEcCtD
Valaciclovir—Decreased appetite—Paclitaxel—lung cancer	0.000361	0.000487	CcSEcCtD
Valaciclovir—Dry mouth—Docetaxel—lung cancer	0.00036	0.000485	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000359	0.000485	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—AKR1C1—lung cancer	0.000359	0.00168	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000359	0.000484	CcSEcCtD
Valaciclovir—Fatigue—Paclitaxel—lung cancer	0.000358	0.000483	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—lung cancer	0.000357	0.000482	CcSEcCtD
Valaciclovir—Asthenia—Gemcitabine—lung cancer	0.000356	0.000481	CcSEcCtD
Valaciclovir—Constipation—Paclitaxel—lung cancer	0.000356	0.00048	CcSEcCtD
Valaciclovir—Pain—Paclitaxel—lung cancer	0.000356	0.00048	CcSEcCtD
Valaciclovir—Confusional state—Docetaxel—lung cancer	0.000355	0.000479	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—lung cancer	0.000355	0.000479	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—AVP—lung cancer	0.000354	0.00166	CbGpPWpGaD
Valaciclovir—Urinary tract disorder—Methotrexate—lung cancer	0.000353	0.000476	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—lung cancer	0.000353	0.000476	CcSEcCtD
Valaciclovir—Oedema—Docetaxel—lung cancer	0.000352	0.000475	CcSEcCtD
Valaciclovir—Anaphylactic shock—Docetaxel—lung cancer	0.000352	0.000475	CcSEcCtD
Valaciclovir—Pruritus—Gemcitabine—lung cancer	0.000351	0.000474	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—lung cancer	0.00035	0.000473	CcSEcCtD
Valaciclovir—Infection—Docetaxel—lung cancer	0.00035	0.000472	CcSEcCtD
Valaciclovir—Feeling abnormal—Etoposide—lung cancer	0.000349	0.000471	CcSEcCtD
Valaciclovir—Diarrhoea—Irinotecan—lung cancer	0.000349	0.00047	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—UGT1A1—lung cancer	0.000349	0.00163	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Etoposide—lung cancer	0.000347	0.000468	CcSEcCtD
Valaciclovir—Nervous system disorder—Docetaxel—lung cancer	0.000346	0.000466	CcSEcCtD
Valaciclovir—Thrombocytopenia—Docetaxel—lung cancer	0.000345	0.000465	CcSEcCtD
Valaciclovir—Tachycardia—Docetaxel—lung cancer	0.000344	0.000464	CcSEcCtD
Valaciclovir—Feeling abnormal—Paclitaxel—lung cancer	0.000343	0.000462	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000342	0.0016	CbGpPWpGaD
Valaciclovir—Skin disorder—Docetaxel—lung cancer	0.000342	0.000462	CcSEcCtD
Valaciclovir—Hypersensitivity—Cisplatin—lung cancer	0.000341	0.00046	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Paclitaxel—lung cancer	0.00034	0.000459	CcSEcCtD
Valaciclovir—Diarrhoea—Gemcitabine—lung cancer	0.00034	0.000458	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—lung cancer	0.000339	0.000457	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—lung cancer	0.000338	0.000456	CcSEcCtD
Valaciclovir—Dizziness—Irinotecan—lung cancer	0.000337	0.000455	CcSEcCtD
Valaciclovir—Urticaria—Etoposide—lung cancer	0.000337	0.000454	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—lung cancer	0.000336	0.000453	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GNG11—lung cancer	0.000336	0.00157	CbGpPWpGaD
Valaciclovir—Anorexia—Docetaxel—lung cancer	0.000336	0.000453	CcSEcCtD
Valaciclovir—Body temperature increased—Etoposide—lung cancer	0.000335	0.000452	CcSEcCtD
Valaciclovir—Abdominal pain—Etoposide—lung cancer	0.000335	0.000452	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—lung cancer	0.000335	0.000452	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000334	0.00157	CbGpPWpGaD
Valaciclovir—Asthenia—Cisplatin—lung cancer	0.000332	0.000448	CcSEcCtD
Valaciclovir—Urticaria—Paclitaxel—lung cancer	0.00033	0.000445	CcSEcCtD
Valaciclovir—Haematuria—Doxorubicin—lung cancer	0.000329	0.000443	CcSEcCtD
Valaciclovir—Abdominal pain—Paclitaxel—lung cancer	0.000329	0.000443	CcSEcCtD
Valaciclovir—Body temperature increased—Paclitaxel—lung cancer	0.000329	0.000443	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000328	0.00154	CbGpPWpGaD
Valaciclovir—Hepatobiliary disease—Doxorubicin—lung cancer	0.000326	0.00044	CcSEcCtD
Valaciclovir—Vomiting—Irinotecan—lung cancer	0.000324	0.000437	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—lung cancer	0.000324	0.000436	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—lung cancer	0.000323	0.000436	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—lung cancer	0.000322	0.000435	CcSEcCtD
Valaciclovir—Rash—Irinotecan—lung cancer	0.000321	0.000434	CcSEcCtD
Valaciclovir—Dermatitis—Irinotecan—lung cancer	0.000321	0.000433	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000321	0.000433	CcSEcCtD
Valaciclovir—Chills—Methotrexate—lung cancer	0.000321	0.000433	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ALDOA—lung cancer	0.00032	0.0015	CbGpPWpGaD
Valaciclovir—Headache—Irinotecan—lung cancer	0.000319	0.000431	CcSEcCtD
Valaciclovir—Insomnia—Docetaxel—lung cancer	0.000319	0.00043	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000318	0.00149	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000318	0.00149	CbGpPWpGaD
Valaciclovir—Diarrhoea—Cisplatin—lung cancer	0.000317	0.000427	CcSEcCtD
Valaciclovir—Paraesthesia—Docetaxel—lung cancer	0.000316	0.000427	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—lung cancer	0.000316	0.000426	CcSEcCtD
Valaciclovir—Vomiting—Gemcitabine—lung cancer	0.000316	0.000426	CcSEcCtD
Valaciclovir—Dyspnoea—Docetaxel—lung cancer	0.000314	0.000424	CcSEcCtD
Valaciclovir—Somnolence—Docetaxel—lung cancer	0.000313	0.000423	CcSEcCtD
Valaciclovir—Rash—Gemcitabine—lung cancer	0.000313	0.000422	CcSEcCtD
Valaciclovir—Dermatitis—Gemcitabine—lung cancer	0.000313	0.000422	CcSEcCtD
Valaciclovir—Hypersensitivity—Etoposide—lung cancer	0.000312	0.000421	CcSEcCtD
Valaciclovir—Headache—Gemcitabine—lung cancer	0.000311	0.00042	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA3—lung cancer	0.000311	0.00146	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.00031	0.00145	CbGpPWpGaD
Valaciclovir—Rhinitis—Doxorubicin—lung cancer	0.00031	0.000419	CcSEcCtD
Valaciclovir—Dyspepsia—Docetaxel—lung cancer	0.00031	0.000418	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—lung cancer	0.00031	0.000418	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—lung cancer	0.000307	0.000414	CcSEcCtD
Valaciclovir—Decreased appetite—Docetaxel—lung cancer	0.000306	0.000413	CcSEcCtD
Valaciclovir—Hypersensitivity—Paclitaxel—lung cancer	0.000306	0.000413	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—lung cancer	0.000306	0.000412	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000305	0.00143	CbGpPWpGaD
Valaciclovir—Oedema peripheral—Doxorubicin—lung cancer	0.000305	0.000411	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Docetaxel—lung cancer	0.000304	0.00041	CcSEcCtD
Valaciclovir—Asthenia—Etoposide—lung cancer	0.000304	0.00041	CcSEcCtD
Valaciclovir—Fatigue—Docetaxel—lung cancer	0.000304	0.00041	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—lung cancer	0.000303	0.000409	CcSEcCtD
Valaciclovir—Nausea—Irinotecan—lung cancer	0.000303	0.000408	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ADCY1—lung cancer	0.000302	0.00142	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG2—lung cancer	0.000302	0.00142	CbGpPWpGaD
Valaciclovir—Constipation—Docetaxel—lung cancer	0.000301	0.000406	CcSEcCtD
Valaciclovir—Pain—Docetaxel—lung cancer	0.000301	0.000406	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—lung cancer	0.000301	0.000406	CcSEcCtD
Valaciclovir—Pruritus—Etoposide—lung cancer	0.0003	0.000405	CcSEcCtD
Valaciclovir—Asthenia—Paclitaxel—lung cancer	0.000298	0.000402	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HPGDS—lung cancer	0.000296	0.00139	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ENO2—lung cancer	0.000296	0.00139	CbGpPWpGaD
Valaciclovir—Nausea—Gemcitabine—lung cancer	0.000295	0.000398	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PPP2R1B—lung cancer	0.000294	0.00138	CbGpPWpGaD
Valaciclovir—Vomiting—Cisplatin—lung cancer	0.000294	0.000397	CcSEcCtD
Valaciclovir—Pruritus—Paclitaxel—lung cancer	0.000294	0.000397	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—lung cancer	0.000293	0.000395	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—AVP—lung cancer	0.000292	0.00137	CbGpPWpGaD
Valaciclovir—Rash—Cisplatin—lung cancer	0.000292	0.000394	CcSEcCtD
Valaciclovir—Dermatitis—Cisplatin—lung cancer	0.000292	0.000393	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—lung cancer	0.000291	0.00136	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000291	0.00136	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Docetaxel—lung cancer	0.00029	0.000392	CcSEcCtD
Valaciclovir—Diarrhoea—Etoposide—lung cancer	0.00029	0.000391	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Docetaxel—lung cancer	0.000288	0.000389	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000288	0.00135	CbGpPWpGaD
Valaciclovir—Anaemia—Methotrexate—lung cancer	0.000288	0.000388	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTT1—lung cancer	0.000287	0.00135	CbGpPWpGaD
Valaciclovir—Diarrhoea—Paclitaxel—lung cancer	0.000284	0.000384	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP2A6—lung cancer	0.000284	0.00133	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GCLC—lung cancer	0.000284	0.00133	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000283	0.00133	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000283	0.00132	CbGpPWpGaD
Valaciclovir—Dizziness—Etoposide—lung cancer	0.00028	0.000378	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—lung cancer	0.00028	0.000377	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000279	0.00131	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000279	0.00131	CbGpPWpGaD
Valaciclovir—Mediastinal disorder—Doxorubicin—lung cancer	0.000279	0.000376	CcSEcCtD
Valaciclovir—Body temperature increased—Docetaxel—lung cancer	0.000279	0.000376	CcSEcCtD
Valaciclovir—Abdominal pain—Docetaxel—lung cancer	0.000279	0.000376	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—lung cancer	0.000279	0.000376	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—lung cancer	0.000278	0.000375	CcSEcCtD
Valaciclovir—Dizziness—Paclitaxel—lung cancer	0.000275	0.000371	CcSEcCtD
Valaciclovir—Nausea—Cisplatin—lung cancer	0.000275	0.000371	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—lung cancer	0.000274	0.000369	CcSEcCtD
Valaciclovir—Cough—Methotrexate—lung cancer	0.000272	0.000366	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—lung cancer	0.00027	0.000364	CcSEcCtD
Valaciclovir—Vomiting—Etoposide—lung cancer	0.00027	0.000364	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ENO1—lung cancer	0.000269	0.00126	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000269	0.00126	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000268	0.00126	CbGpPWpGaD
Valaciclovir—Rash—Etoposide—lung cancer	0.000267	0.000361	CcSEcCtD
Valaciclovir—Dermatitis—Etoposide—lung cancer	0.000267	0.00036	CcSEcCtD
Valaciclovir—Headache—Etoposide—lung cancer	0.000266	0.000358	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—lung cancer	0.000266	0.000358	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—lung cancer	0.000265	0.000357	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—lung cancer	0.000265	0.000357	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—lung cancer	0.000265	0.000357	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000265	0.00124	CbGpPWpGaD
Valaciclovir—Tension—Doxorubicin—lung cancer	0.000264	0.000357	CcSEcCtD
Valaciclovir—Vomiting—Paclitaxel—lung cancer	0.000264	0.000357	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000263	0.000355	CcSEcCtD
Valaciclovir—Rash—Paclitaxel—lung cancer	0.000262	0.000354	CcSEcCtD
Valaciclovir—Dermatitis—Paclitaxel—lung cancer	0.000262	0.000353	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—lung cancer	0.000262	0.000353	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—lung cancer	0.000261	0.000352	CcSEcCtD
Valaciclovir—Headache—Paclitaxel—lung cancer	0.00026	0.000351	CcSEcCtD
Valaciclovir—Hypersensitivity—Docetaxel—lung cancer	0.00026	0.00035	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	0.000259	0.00122	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000259	0.00121	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000259	0.00121	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000256	0.0012	CbGpPWpGaD
Valaciclovir—Confusional state—Methotrexate—lung cancer	0.000256	0.000345	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—lung cancer	0.000254	0.000343	CcSEcCtD
Valaciclovir—Asthenia—Docetaxel—lung cancer	0.000253	0.000341	CcSEcCtD
Valaciclovir—Infection—Methotrexate—lung cancer	0.000252	0.00034	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—lung cancer	0.000252	0.00118	CbGpPWpGaD
Valaciclovir—Nausea—Etoposide—lung cancer	0.000252	0.00034	CcSEcCtD
Valaciclovir—Pruritus—Docetaxel—lung cancer	0.000249	0.000336	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—lung cancer	0.000249	0.000336	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—lung cancer	0.000249	0.000336	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—lung cancer	0.000249	0.000335	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—lung cancer	0.000248	0.000334	CcSEcCtD
Valaciclovir—Nausea—Paclitaxel—lung cancer	0.000247	0.000333	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—lung cancer	0.000247	0.000333	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000246	0.00115	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	0.000244	0.00114	CbGpPWpGaD
Valaciclovir—Anorexia—Methotrexate—lung cancer	0.000242	0.000327	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP2E1—lung cancer	0.000242	0.00113	CbGpPWpGaD
Valaciclovir—Leukopenia—Doxorubicin—lung cancer	0.000241	0.000325	CcSEcCtD
Valaciclovir—Diarrhoea—Docetaxel—lung cancer	0.000241	0.000325	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	0.000241	0.00113	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NQO1—lung cancer	0.000239	0.00112	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000236	0.0011	CbGpPWpGaD
Valaciclovir—Cough—Doxorubicin—lung cancer	0.000235	0.000317	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000234	0.0011	CbGpPWpGaD
Valaciclovir—Convulsion—Doxorubicin—lung cancer	0.000233	0.000315	CcSEcCtD
Valaciclovir—Dizziness—Docetaxel—lung cancer	0.000233	0.000314	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—lung cancer	0.000233	0.000314	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000232	0.00109	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000231	0.000312	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	0.00023	0.00108	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—lung cancer	0.00023	0.00108	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	0.00023	0.00108	CbGpPWpGaD
Valaciclovir—Insomnia—Methotrexate—lung cancer	0.00023	0.00031	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—lung cancer	0.000229	0.000309	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—lung cancer	0.000229	0.000309	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—lung cancer	0.000229	0.000309	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—lung cancer	0.000228	0.000308	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000228	0.000307	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RAF1—lung cancer	0.000228	0.00107	CbGpPWpGaD
Valaciclovir—Dyspnoea—Methotrexate—lung cancer	0.000226	0.000305	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—lung cancer	0.000226	0.000305	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—lung cancer	0.000224	0.000303	CcSEcCtD
Valaciclovir—Vomiting—Docetaxel—lung cancer	0.000224	0.000302	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—lung cancer	0.000224	0.000302	CcSEcCtD
Valaciclovir—Rash—Docetaxel—lung cancer	0.000222	0.0003	CcSEcCtD
Valaciclovir—Dermatitis—Docetaxel—lung cancer	0.000222	0.000299	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—lung cancer	0.000222	0.000299	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—lung cancer	0.000221	0.000298	CcSEcCtD
Valaciclovir—Headache—Docetaxel—lung cancer	0.000221	0.000298	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—lung cancer	0.00022	0.000297	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—lung cancer	0.00022	0.000297	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—lung cancer	0.000219	0.000296	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—lung cancer	0.000219	0.000295	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—lung cancer	0.000218	0.000295	CcSEcCtD
Valaciclovir—Pain—Methotrexate—lung cancer	0.000217	0.000293	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—lung cancer	0.000216	0.000291	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—lung cancer	0.000215	0.00029	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—STK11—lung cancer	0.000215	0.00101	CbGpPWpGaD
Valaciclovir—Tachycardia—Doxorubicin—lung cancer	0.000215	0.00029	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	0.000214	0.001	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	0.000214	0.001	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000214	0.001	CbGpPWpGaD
Valaciclovir—Skin disorder—Doxorubicin—lung cancer	0.000214	0.000288	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—lung cancer	0.00021	0.000283	CcSEcCtD
Valaciclovir—Nausea—Docetaxel—lung cancer	0.000209	0.000282	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—lung cancer	0.000209	0.000282	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RAF1—lung cancer	0.000208	0.000976	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Methotrexate—lung cancer	0.000208	0.00028	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000202	0.000947	CbGpPWpGaD
Valaciclovir—Urticaria—Methotrexate—lung cancer	0.000202	0.000272	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—lung cancer	0.000201	0.000271	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—lung cancer	0.000201	0.000271	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.0002	0.00027	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTP1—lung cancer	0.000199	0.000933	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000199	0.000932	CbGpPWpGaD
Valaciclovir—Insomnia—Doxorubicin—lung cancer	0.000199	0.000268	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—lung cancer	0.000197	0.000266	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—lung cancer	0.000196	0.000264	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—lung cancer	0.000196	0.000264	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CAT—lung cancer	0.000194	0.000908	CbGpPWpGaD
Valaciclovir—Dyspepsia—Doxorubicin—lung cancer	0.000194	0.000261	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000193	0.000903	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000192	0.000901	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000192	0.000901	CbGpPWpGaD
Valaciclovir—Decreased appetite—Doxorubicin—lung cancer	0.000191	0.000258	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00019	0.000256	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—lung cancer	0.00019	0.000256	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ABCB1—lung cancer	0.000189	0.000883	CbGpPWpGaD
Valaciclovir—Pain—Doxorubicin—lung cancer	0.000188	0.000254	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—lung cancer	0.000188	0.000254	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—lung cancer	0.000187	0.000252	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—TYMS—lung cancer	0.000185	0.000868	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—lung cancer	0.000183	0.000858	CbGpPWpGaD
Valaciclovir—Asthenia—Methotrexate—lung cancer	0.000182	0.000246	CcSEcCtD
Valaciclovir—Feeling abnormal—Doxorubicin—lung cancer	0.000181	0.000244	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	0.00018	0.000842	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Doxorubicin—lung cancer	0.00018	0.000243	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—lung cancer	0.00018	0.000242	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	0.000179	0.000837	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	0.000177	0.000829	CbGpPWpGaD
Valaciclovir—Urticaria—Doxorubicin—lung cancer	0.000175	0.000236	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000174	0.000816	CbGpPWpGaD
Valaciclovir—Body temperature increased—Doxorubicin—lung cancer	0.000174	0.000234	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—lung cancer	0.000174	0.000234	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—lung cancer	0.000174	0.000234	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP1A1—lung cancer	0.000174	0.000813	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ERCC2—lung cancer	0.000172	0.000806	CbGpPWpGaD
Valaciclovir—Dizziness—Methotrexate—lung cancer	0.000168	0.000227	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	0.000167	0.000782	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Doxorubicin—lung cancer	0.000162	0.000219	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000162	0.000757	CbGpPWpGaD
Valaciclovir—Vomiting—Methotrexate—lung cancer	0.000161	0.000218	CcSEcCtD
Valaciclovir—Rash—Methotrexate—lung cancer	0.00016	0.000216	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—lung cancer	0.00016	0.000216	CcSEcCtD
Valaciclovir—Headache—Methotrexate—lung cancer	0.000159	0.000215	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—lung cancer	0.000158	0.000213	CcSEcCtD
Valaciclovir—Pruritus—Doxorubicin—lung cancer	0.000156	0.00021	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—lung cancer	0.000151	0.000203	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—lung cancer	0.00015	0.000203	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—APOA1—lung cancer	0.000149	0.000698	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	0.000148	0.000695	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	0.000148	0.000692	CbGpPWpGaD
Valaciclovir—Dizziness—Doxorubicin—lung cancer	0.000145	0.000196	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000144	0.000673	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.000143	0.000668	CbGpPWpGaD
Valaciclovir—Vomiting—Doxorubicin—lung cancer	0.00014	0.000189	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—lung cancer	0.000139	0.000187	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—lung cancer	0.000139	0.000187	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—lung cancer	0.000138	0.000186	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000138	0.000644	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—lung cancer	0.000136	0.000637	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—lung cancer	0.000131	0.000176	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—POMC—lung cancer	0.000129	0.000606	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000128	0.000598	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CREBBP—lung cancer	0.000126	0.00059	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	0.000124	0.00058	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	0.00012	0.000562	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—lung cancer	0.00012	0.00056	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—lung cancer	0.000118	0.000553	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000116	0.000545	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	0.000114	0.000532	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	0.000109	0.00051	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000108	0.000506	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—lung cancer	0.000104	0.000488	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—lung cancer	0.000103	0.000483	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	0.000101	0.000474	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	9.85e-05	0.000462	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	9.61e-05	0.00045	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	9.47e-05	0.000444	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	9.15e-05	0.000428	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—lung cancer	9e-05	0.000422	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	8.99e-05	0.000421	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—EP300—lung cancer	8.58e-05	0.000402	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	8.13e-05	0.000381	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	8.02e-05	0.000376	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	7.51e-05	0.000352	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	6.79e-05	0.000318	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—lung cancer	6.35e-05	0.000297	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—lung cancer	5.19e-05	0.000243	CbGpPWpGaD
